Last edition
News about "Mankind Pharma "
Mankind Pharma Partners with OpenAI to Embed AI Across Operations
Mankind Pharma has announced a strategic collaboration with OpenAI, aimed at integrating artificial intelligence across its entire value chain. The move marks one of the first times an Indian pharmaceutical company has committed to fully embedding advanced AI into its core operations.
Mankind Pharma | 18/09/2025 | By Darshana
Mankind Pharma Gets CDSCO Nod to Begin Phase 1 Trials of Novel Autoimmune Drug Candidate MKP11093
Mankind Pharma Ltd., India’s 4th largest pharmaceutical company, today announced that it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to initiate a Phase 1 clinical trial of MKP11093, a novel, orally administered Janus kinase-1 (JAK-1) inhibitor.
Mankind Pharma | 08/09/2025 | By Darshana
Mankind Pharma Expands into Sri Lanka With New Subsidiary
Mankind Pharma has incorporated a wholly owned subsidiary, Mankind Pharma Lanka (Private) Ltd., in Sri Lanka as part of its international expansion strategy.
Mankind Pharma | 26/07/2025 | By Dineshwori | 105
Mankind Pharma, Innovent Biologics to Commercialize Sintilimab for Cancer Care
This strategic collaboration aims to address the critical challenges in cancer treatment and improve patient access to innovative therapeutic options in the region.
Mankind Pharma | 27/12/2024 | By Aishwarya | 182
Mankind Pharma Bags CCI Approval for BSV Acquisition
The proposed transaction involves the acquisition of 100 percent shareholding of Bharat Serums and Vaccines Ltd. (BSV) by Mankind Pharma Ltd.
Mankind Pharma | 10/10/2024 | By Aishwarya | 273
Mankind Pharma to Acquire Bharat Serums and Vaccines
Mankind Pharma has signed a definitive agreement to acquire a 100 percent stake in Bharat Serums and Vaccines Ltd. (BSV) from Advent International, for an enterprise value of approx. INR 13,630 Crores, subject to closing-related adjustments.
Mankind Pharma | 26/07/2024 | By Aishwarya | 460
Mankind Pharma Signs License Deal with Takeda to Commercialise Acidity Drug in India
Mankind Pharma has signed a non-exclusive patent licence agreement with Takeda Pharmaceuticals for commercialising acidity drug Vonoprazan in the Indian market.
Mankind Pharma | 22/07/2024 | By Aishwarya | 519
Mankind Pharma files DRHP with SEBI
The company’s initial public offering comprises an offer for the sale of 40,058,884 equity shares of face value Rs 1
Mankind Pharma | 19/09/2022 | By Sudeep Soparkar | 551
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy